EcoDrugPlus

Ribosomal Protein L34

Ensembl ID : ENSLACG00000006291
Gene Symbol: RPL34
4 Cross references
364 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSLACG00000018394
Gene Symbol: RPL35
4 Cross references
300 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSLACG00000004096
Gene Symbol: RPL35A
4 Cross references
452 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSLACG00000015161
Gene Symbol: RPL36
4 Cross references
396 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSLACG00000011578
Gene Symbol: RPL37A
4 Cross references
420 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSLACG00000008876
Gene Symbol: RPL39
4 Cross references
246 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSLACG00000006259
Gene Symbol: RPL4
4 Cross references
344 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSLACG00000010794
Gene Symbol: RPL5
4 Cross references
530 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSLACG00000007120
Gene Symbol: RPL6
3 Cross references
484 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSLACG00000000137
Gene Symbol: RPL6
1 Cross references
484 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSLACG00000001543
Gene Symbol: RPL6
1 Cross references
484 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSLACG00000003571
Gene Symbol: RPL7
2 Cross references
492 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).